常规改善肝脏缺血-再输损伤通过向CD36抑制肝细胞铁亡
Zhenlong Liu1, Miaomiao Wang1, Liangyun Li1
1Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
International immunopharmacology
|January 23, 2026
概括
在肝缺血-再输液损伤 (HIRI) 期间,CD36促进肝损伤和铁. 鲁丁是一种天然化合物,抑制CD36,通过向CD36/FABP5通路,为HIRI提供潜在的治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 肝缺血再输损伤 (HIRI) 是一个主要的并发症,限制了肝移植的成功.
- 肝细胞铁是驱动HIRI的一个关键机制.
- 脂肪酸转位酶CD36在HIRI和铁亡中的作用尚不清楚.
研究的目的:
- 研究CD36在HIRI和铁亡中的作用.
- 通过向CD36.6,探索鲁丁作为HIRI的潜在治疗剂.
主要方法:
- 产生的全和肝细胞特异性CD36淘汰赛小鼠.
- 使用初级肝细胞的体外低氧-重氧化 (H/R) 模型.
- 研究了涉及CD36,FABP5和HNF4α的分子机制.
主要成果:
- 在HIRI和H/R模型中,CD36表达被上调.
- 在HIRI中,CD36淘汰赛减轻了肝损伤和铁亡.
- 鲁丁通过向CD36/FABP5轴来抑制CD36转录,并通过向CD36/FABP5轴对HIRI进行保护.
结论:
- CD36通过促进FABP5-介导的脂质代谢和铁亡来加剧HIRI.
- 鲁丁通过 CD36 抑制证明了 HIRI 的治疗潜力.
- CD36/FABP5轴代表了HIRI的一个新的治疗点.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
265
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
265
Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
220
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
220
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
653
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
653
Hepatic Drug Excretion: Influencing Factors
543
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
543
Hepatic Drug Clearance: Role of Transporters
305
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
305


